NuuVim review
A rare same-price injectable/oral parity — $79/mo semaglutide, $133/mo tirzepatide either way — but that's a standing new-patient tier with an unpublished refill rate, its brand Ozempic and Zepbound run well above manufacturer self-pay pricing, and its own live site doesn't confirm the all-50-states claim found elsewhere.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
NuuVim at a glance
- Semaglutide
- $79/mo
- Tirzepatide
- $133/mo
- Coverage
- Not disclosed by NuuVim's own live site — not verified by observation
- Brand-name
- Yes
How we scored NuuVim
Each score comes out of NuuVim's published pricing, disclosures and oversight, and the six combine into the 64/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Workable around a household, though it isn't built around one.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.nuuvim.com
$79 and $133 on the new-patient tier, with injectable and oral offered at the same price — genuine parity, and uncommon. What is missing is the second act: the refill price after that tier is published nowhere on the site. NuuVim states plainly that it does not compound in-house.
What to expect when you sign up
We walked NuuVim's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action leaves nuuvim.com for start.nuuvim.com, a separate host
- 2The intake responded HTTP 200 when checked on 2026-08-21
- 3Walked to the intake entry only. No personal information was submitted, so nothing past the entry screen is asserted here
What we noticed
- The intake runs on Bask Health rather than on the provider's own software
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
- Intake is hosted on start.nuuvim.com, so the company you fill the form in with is not the domain you started on
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $79 | Injectable or oral — New GLP-1 UsersPriced the same whether injectable or oral. A standing new-patient tier, not a countdown-timer promo — but NuuVim doesn't publish the follow-on 'current user' refill rate. |
| Compounded tirzepatide | $133 | Injectable or oral — New GLP-1 UsersSame injectable/oral price parity and new-patient-tier caveat as semaglutide. |
| Brand semaglutide | $1498 | Brand OzempicPriced far above LillyDirect/NovoCare-style manufacturer self-pay channels. |
| Brand tirzepatide | $1892 | Brand ZepboundSame pattern — well above manufacturer self-pay pricing. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from NuuVim's public disclosures at last review and change often; confirm the current number on NuuVim's own site.
What we like
- Injectable and oral priced identically on both molecules — a real, uncommon needle-free option at no markup
- LegitScript-certified and HIPAA-compliant, with a clear, verbatim FDA compounding disclaimer
- One of the lowest new-patient headline prices on this roster
The caveats
- The $79/$133 figures are a new-patient tier; the follow-on refill price isn't published anywhere on-site
- Brand Ozempic ($1,498/mo) and Zepbound ($1,892/mo) both run far above the manufacturers' own self-pay programs
- A third-party directory's 'all 50 states + DC' claim could not be confirmed on NuuVim's own live site
NuuVim for mothers: our verdict
A rare same-price injectable/oral parity — $79/mo semaglutide, $133/mo tirzepatide either way — but that's a standing new-patient tier with an unpublished refill rate, its brand Ozempic and Zepbound run well above manufacturer self-pay pricing, and its own live site doesn't confirm the all-50-states claim found elsewhere. It runs about $79/month, flat across every dose — toward the affordable end of what we track.
We weigh NuuVim the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What NuuVim actually costs
- Compounded semaglutide — Injectable or oral — New GLP-1 Users: $79/mo
- Compounded tirzepatide — Injectable or oral — New GLP-1 Users: $133/mo
- Brand-name semaglutide — Brand Ozempic: $1498/mo
- Brand-name tirzepatide — Brand Zepbound: $1892/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications NuuVim prescribes
NuuVim prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. It can also route you to FDA-approved brand pens rather than only compounded vials, and those carry the manufacturer's own pregnancy and lactation labeling, which is a cleaner document to take to an OB.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where NuuVim fits — and where it doesn't — for mothers
Worth it if…
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
NuuVim is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who wants a genuinely needle-free option at no price penalty and will confirm the refill rate and her own state directly before committing past the first month.
Alternatives to NuuVim
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing NuuVim
Head-to-head & alternatives
NuuVim, answered
- Is NuuVim's oral option really the same price as the injection?
- Yes — both semaglutide ($79/mo) and tirzepatide ($133/mo) are priced identically whether you take the injectable or oral form, a genuinely uncommon parity in this category, where oral routes usually cost more.
- Will NuuVim's price stay at $79 or $133 after the first month?
- That's the New GLP-1 Users price, framed as a standing new-patient tier rather than a limited-time promo — but NuuVim doesn't publish what the follow-on 'current user' refill rate actually is. Ask directly before assuming the intro number holds.
- Is brand-name Ozempic or Zepbound cheaper through NuuVim?
- No — NuuVim lists Ozempic at $1,498/mo and Zepbound at $1,892/mo, both well above what you'd pay through the manufacturers' own direct self-pay programs (LillyDirect, NovoCare). Compare both routes before choosing the brand path here.
- Does NuuVim serve all 50 states?
- A third-party directory claims all 50 states plus DC, but that could not be confirmed directly on NuuVim's own live site as of this check — treat it as unconfirmed and ask directly.
Pricing, states and verification reflect NuuVim's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.